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Elevated levels of the calcium-binding protein S100A4 pro-
mote metastasis and in carcinoma cells are associated with
reduced survival of cancer patients. S100A4 interacts with target
proteins that affect a number of activities associated
with metastatic cells. However, it is not known how many of
these interactions are required for S100A4-promoted metasta-
sis, thus hampering the design of specific inhibitors of
S100A4-induced metastasis. Intracellular S100A4 exists as a
homodimer through previously identified, well conserved,
predominantly hydrophobic key contacts between the sub-
units. Here it is shown that mutating just one key residue,
phenylalanine 72, to alanine is sufficient to reduce the metas-
tasis-promoting activity of S100A4 to 50% that of the wild
type protein, and just 2 or 3 specific mutations reduces the
metastasis-promoting activity of S100A4 to less than 20%
that of the wild type protein. These mutations inhibit the
self-association of S100A4 in vivo and reduce markedly the
affinity of S100A4 for at least two of its protein targets, a
recombinant fragment of non-muscle myosin heavy chain
isoform A, and p53. Inhibition of the self-association of S100
proteins might be a novel means of inhibiting their metasta-
sis-promoting activities.
S100A4 protein belongs to the S100 family of EF-hand con-
taining calcium-binding proteins. The presence of S100A4 pro-
tein in human carcinoma cells has been associatedwith reduced
survival in patients suffering from malignant melanoma (1),
non-small cell lung carcinoma (2, 3), and cancers of the breast
(4, 5), colorectum (6, 7), urinary bladder (8, 9), gall bladder (10),
esophagus (11), mouth (12), and stomach (13). S100A4 was the
first S100 protein to be shown to promotemetastases in amodel
system of breast cancer (14).
S100A4 protein interacts with a number of intracellular tar-
gets, including the heavy chain of non-muscle myosin (15, 16)
isoform A (NMMIIHCA)5 in vitro (17) and in vivo (18), by
which itmight affect cellmotility (19, 20). S100A4 also interacts
with the C-terminal region of the tumor suppressor protein,
p53 (21, 22), affecting p53 oligomerization (22) and cell apopto-
sis (21). S100A4 also exhibits less well characterized interac-
tions with other intracellular proteins, -liprin (23) and tropo-
myosin (24), and with extracellular proteins, annexin II and
plasminogen (25).
S100A4 exists as a self-assembling homodimer, and the
dimerization arises fromhydrophobic residues, particularly Ile-
12, Val-13, Phe-16 in helix I and Phe-72, Tyr-75, Phe-78, and
Leu-79 in helix 4 (26) in humanS100A4. In the yeast two-hybrid
system, interaction between newly synthesized S100A4mutant
molecules andwild type S100A4was not detectable for proteins
containing single point mutations, F72A, Y75K, or F78A (26).
However, F78A behaved like wild type protein for dimerization
in separate immunoprecipitation experiments and for interac-
tion with NMMIIHCA (27). Single mutations of either F72Q or
Y75K prevented dimerization of S100A4 and also interaction
with non-muscle myosin (27). However, the effect of such
dimerization-disrupting mutations on the biological activity of
S100A4 is presently unknown.
EXPERIMENTAL PROCEDURES
Expression and Purification of Human S100A4—Wild type
S100A4 cDNAwas cloned into the NdeI/BamHI sites of bacte-
rial expression vector pET15b (Novagen) and recombinant
protein produced in Escherichia coli C41 (28). The fraction
containing the S100A4 recombinant protein was dialyzed
against phosphate-buffered saline (PBS), and the purity of the
S100A4 was checked by SDS-15% (w/v) polyacrylamide gel
electrophoresis. To remove theHis tag, the purified proteinwas
incubated with 100 units/ml thrombin and immobilized on
Affi-10 resin (Bio-Rad) for12 h with shaking. After centrifu-
gation at 5000 g for 5min to remove the immobilized throm-
bin, the supernatant containing the cleaved S100A4 protein
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was collected and loaded onto a His-select column to remove
any undigested His-tagged proteins.
Site-directed Mutagenesis—Mutations at amino acids 72,
72.78, and 16.72.78 encoded by the S100A4 cDNA cloned into
pET15b were performed using a QuikChange site-directed
mutagenesis kit (Stratagene). Pairs of complementary oligonu-
cleotides (supplemental Data 1) containing the desired muta-
tion(s) were used to change phenylalanine residues at positions
16, 72, and 78 to alanine, glutamine, and alanine, respectively.
PCR reactions were set up as described previously (28) with an
initial denaturing step at 95 °C for 3min, 16 cycles of 95 °C for 1
min, 55 °C for 1min, and 68 °C for 10minwith a final extension
step of 68 °C for 15 min, and the desired mutations were con-
firmed by DNA sequencing. The mutagenized constructs were
transformed into E. coli C41 for propagation and recombinant
protein production.
Transfection ofMammary Cell Lines—The S100A4 wild type
and mutated cDNAs in pET-15b were amplified by PCR using
a pair of primers bearing (underlined) BamHI and HindIII
restriction enzyme sites (forward human S100A4 primer, 5-
CCGGATCC70ATGGCGTGCCCTCTGG85; reverse-human
S100A4 primer, 5-CGAAGCTTT375CATTTCTTCCTGGG-
CTG358, numbering is from GenBank accession number
NM_002961). The PCR products were cloned into
pCDNA3.1() vector that had been double-digested with
BamHI and HindIII. 2–3 g of recombinant constructs were
used to transfect the rat mammary tumor-derived Rama 37
cells (29) using Lipofectamine 2000 reagent (Invitrogen), and
transfected cells were selected inmediumcontaining 0.8mg/ml
Geneticin, replaced every 2–3 days. Surviving colonies of cells
were picked and expanded, and the remaining survivors were
expanded as a pool. The resulting cloned and pooled transfected
cells were tested for the presence of S100A4 proteins and actin
by Western blotting (28, 30, 31). Cell lines and pools with
similar levels of S100A4 proteins were selected.
Growth rates of transfected cell clones were determined by
plating 12,000 cells/ml in triplicate and counting the number of
cells after 48 h of incubation. The growth rates in cells/h for the
various transfected cell lines were compared using Student’s t
tests on Stats Direct software Version 2.6.2 (Stats Direct Ltd.,
Altringham, UK).
In Vitro Caspase Activity Assays—In vitro caspase-3 activity
was measured using Caspase-Glo 3/7 assay kit (Promega,
Southampton, UK) according to the manufacturer’s instruc-
tions. Briefly, 4 104 cells of the indicated cell lines were plated
in white 96-multiwell microplates (Greiner, Stonehouse, UK).
24 h after plating, basal caspase-3 activity was assessed by lumi-
nescence measurement using a 5-s measurement time in a
PerkinElmer Life Sciences EnVision plate reader.
Immunofluorescent Staining—Rama 37 cell lines were cul-
tured as described above and plated onto fibronectin-coated
(2.5 mg/cm2) glass coverslips in 24-well plates and grown for
48 h. Cells were washed once in cytoskeleton buffer (CB: 150
mM NaCl, 5 mM MgCl2, 5 mM EGTA, 5 mM glucose, 10 mM
MES, pH 6.1) before fixation with methanol at 18 °C for 20
min. Cells were then further washed in CB before being perme-
abilized with 0.2% (v/v) Triton X-100 in CB for 10 min, rinsed
with CB, and blocked with blocking solution (3% (w/v) bovine
serum albumin in CB) for 60min. Samples were incubated with
primary antibodies against non-muscle myosin IIA (Covance,
Princeton, NJ) and S100A4 (DAKO, Ely, UK) in blocking solu-
tion for 45 min at 37 °C. After washing three times with block-
ing solution, cells were incubatedwith anti-rabbit and anti-goat
antibodies labeled with fluorescein isothiocyanate and Cy3,
respectively, in blocking solution for 45 min at 37 °C. After
washing with blocking solution, coverslips were rinsed with
water, mounted in Vectashield mounting medium (Vector,
Peterborough, UK), and viewed using a Zeiss LSM510 confocal
laser scanning microscope.
In Vivo Metastasis Assay—Transfected cell clones and
pools were subjected to metastasis assays as described previously
(14, 31). Lung tissue for detection of metastases was fixed in for-
malin, embedded in paraffin wax, sectioned, and stained with
hematoxylin andeosin (29). Invasionof theprimary tumor cells in
vivowas determined as described previously (32). Animalswere
maintained according to United Kingdom Coordinating Com-
mittee for Cancer Research guidelines under UK Home Office
Project License 40/2395 to Professor P. S. Rudland.
Transwell Cell Migration Assays—Twelve-well (wells 1.0
cm2) Transwell permeable devices (Corning Costar) with
8.0-m pore size polycarbonate membranes were used to
measure chemotactic migration of 1  105 cells induced by a
1–5% (v/v) fetal calf serumgradient over 24 h. Thewells and the
inserts were washed three times with PBS, and the filters were
fixed and stained using a Diffquik histochemical kit (Reagena,
Toivala, Finland) following the manufacturer’s instructions.
The stained cells on the lower side of the membrane were
counted using a light microscope with a 20 objective lens.
Mean values S.D. were of 4 replicate wells.
Binding of rS100A4 to Calcium, rNMMIIHCA, and p53—
The binding of Ca2 to apoS100A4 proteins was determined
using isothermal titration calorimetry (ITC). Traces of Ca2
were stripped from the recombinant protein samples by adding
1 mM EGTA before dialysis against 20 mM Tris-Cl, pH 7.4, 140
mMNaCl overnight. The dialysate buffer was saved for diluting
the protein samples,makingCaCl2 solution and blank ITC con-
trols. An iTC200 Microcalorimeter (GE Healthcare) was used
for all measurements. The sample cell was filled with 250 l of
0.25 mM mutant 72 protein, 0.5 mM mutant 72.78, or 0.6 mM
mutant 16.72.78. 1 mM CaCl2 titrant dissolved in the dialysate
mentioned above was injected in 2-l aliquots with injection
durations of 4 s and a 150-s interval between injections, except
the first injection, for which the injection volume and duration
were 0.4l and 2s, respectively, to remove an irregularity due to
capillary action. Cell temperature was set at 30 °C for all exper-
iments. A blank control, acquired by adding the titrant into the
buffer without protein, was subtracted from the titration curve.
The results were analyzed using the “Origin for ITC” software
supplied with iTC200 Microcalorimeter.
Binding of S100A4 to a recombinant protein consisting of the
149 C-terminal amino acids of NMMIIHCA or recombinant
wild type p53 (GenWay Biotech Inc., San Diego, Ca; catalog no.
10-663-45596) was tested using a dual-Channel IAsys resonant
mirror biosensor (Neosensors, Sedgefield, UK) as described
previously (33, 34). rNMMIIHCA rods or recombinant p53
were covalently bound to aminosilane sensor surfaces (Neosen-
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sors) using bissuccinimidyl suberate (Perbio, Chester, UK) as
the cross-linker according to supplier’s instructions. Different
concentrations of S100A4 proteins were injected into the
rNMMIIHCA- or recombinant p53-derivatized sensor cuvette
that contained 45l of 1PBS buffer containing 0.5mMCaCl2,
0.02% (v/v) Tween 20. The immobilized protein was regener-
ated by washing with 20mMHCl, which removed all detectable
S100A4 proteins. No detectable binding of S100A4 was
observed to non-derivatized aminosilane surfaces (not shown).
The kinetics of the binding of S100A4 to rNMMIIHCA or p53
proteins were calculated using non-linear curve fitting Fast Fit
software (Neosensors) (34). The association and dissociation
curves fit a single-site bindingmodel at least aswell as a two-site
binding model.
Protein Interactions in Living Cells—Fluorescence resonance
energy transfer (FRET) by fluorescence lifetime imaging
(FLIM) was used to test the dimerization of wild type and
mutant S100A4 proteins and their binding to rNMMIIHCA in
vivo. The S100A4 wild type and mutant cDNAs were amplified
by PCR using a pair of oligonucleotides having HindIII and
BamHI restriction enzyme sites (forward primer (restriction
sites are underlined), 5-CCGGATCC70ATGGCGTGCCC-
TCTGG85; reverse primer, 5-CGAAGCTT375TCATTTCTT-
CCTGGGCTG358, numbering is from GenBankTM accession
number NM_002961) and inserted into pYFP and pAmCyan
vectors such that the fluorescent protein resided at the N ter-
minus of the S100A4 protein (18). For the insertion of non-
muscle myosin rNMMIIHCA DNA (GenBankTM accession
number M31013) into pYFP and pAmCyan vectors, a pair of
oligonucleotides was used as described previously (33). For
FLIM experiments, HeLa cells, grown in Dulbecco’s modified
Eagle’smedium containing 10% (v/v) fetal calf serum at 37 °C in
10% (v/v) CO2, were transfected with 3 g of plasmid DNAs
using FuGENE6 (RocheApplied Science). Each pAmCyan con-
struct was transfected alone or with a pYFP construct. Empty
vector pYFP or pAmCyan were also used as a negative control.
For FRET-FLIM experiments, 100,000 living cells/well of each
transfectionwere plated out for 12–24 h onto IWAKI glass base
dishes (Asahi Techno Glass Corp., Japan). An in-house-built
confocal laser-scanning microscope system was used to detect
the interaction of AmCyan and YFP at a single cell level. A
frequency-doubled laser (Coherent, Santa Clara, CA;   435
nm, 76 MHz repetition rate) was delivered to the sample via a
dichroic mirror (51017, Chroma Technology, Rockingham,
VT) focused through the 1.3-NAZeiss oil immersion lens (Carl
Zeiss). The FLIM images were analyzed for FRET valuation
using SPCImage (Becker-Hickl GmbH) FLIM analysis software
(18).
Analytical Gel Filtration Chromatography—60–100 g of
purified protein samples dialyzed overnight against PBS buffer
were applied to Superdex 75 10/300 GL columns (GE Health-
care) equilibrated with PBS. In some experiments proteins dia-
lyzed against TBS buffer (20 mM Tris-HCl, pH 7.4, 140 mM
NaCl, pH 7.4) were applied to Superdex 200 10/300 GL col-
umns equilibrated with TBS buffer either in the presence or
absence of calcium. Columns were operated at a flow rate of 0.5
ml/min, and elution was monitored at 215 nm. Separations on
Superdex 200were calibrated using-amylase (molecularmass
200 kDa), bovine -globulin (molecular mass monomer, 160
kDa; dimer, 320 kDa), bovine serum albumin (molecular mass
66 kDa), cytochrome c (molecular mass 12.4 kDa).
RESULTS
cDNAs encoding three mutant S100A4 proteins were pro-
duced: mutant 72, in which phenylalanine 72 was converted to
glutamine, Mutant 72.78, in which phenylalanines 72 and 78
were converted to glutamine and alanine, respectively, and
Mutant 16.72.78, in which phenylalanines 16, 72, and 78 were
converted to alanine, glutamine, and alanine, respectively. Ex-
pression plasmid constructs bearing wild type S100A4 or these
mutant cDNAswere transfected into Rama 37 cells. The benign
non-metastatic rat mammary tumor-derived cell line, Rama 37
(29), was used because expression ofwild type rat (14) or human
(35) S100A4 in these cells induces a metastatic phenotype.
After selection inGeneticin, permanent cell clones and pools of
the transfected Rama 37 cells were isolated.
Immunofluorescent staining of cells for non-muscle myosin
IIA showed the presence of fibers in the mock-transfected cells
and a more punctate staining pattern in the wild type S100A4-
transfected cells. Mutant 72 cells resembled the S100A4-trans-
fected cells in this regard. Generally, mutants 72.78 and
16.72.78 resembled the mock-transfected cells, with less punc-
tate staining and more evidence of fibers. The fibers, however,
were not as well developed as in the mock-transfected cells and
seemed to be collapsed toward the periphery of the cells. The
distribution of S100A4 generally reflected filament structures
apart from being present at a low level in the mock-transfected
cell line (supplemental Data 2), and the transfected pools exhib-
ited similar characteristics (not shown). S100A4was also found
betweenmyosin fibers and particularly at the tips of fibers at the
cell periphery.
The transfected Rama 37 cloned cell lines did not exhibit
significantly different growth rates from one another (cell lines
transfected with empty vector, mutant 72, mutant 72.78, and
mutant 16.72.78 compared with wild type, p 0.37, 0.24, 0.21,
0.61, respectively, Student’s t test). This result suggests that
expression of wild type S100A4 does not increase the growth
rate of cells, supporting previous reports in mouse (19) and rat
(35) cells and that the expression of the mutant S100A4 pro-
teins per se does not adversely affect the growth rate of the cells.
Determination of caspase 3/7 activity in two experiments
(supplemental Data 3) as a marker of apoptosis showed that
there were no consistent differences in caspase 3/7 activities
between cells expressing wild type or mutant S100A4 proteins,
a result that is entirely consistent with the similarity in growth
rates of these cells in culture. However, there were minor vari-
ations between the various mutants in the two experiments,
with mutants 72 and 16.72.78 showing no change or signifi-
cantly less caspase 3/7 activity than wild type S100A4 (mutant
72, p  0.6 or 0.002; mutant 16.72.78, p  0.001 or  0.001,
Student’s t test) and mutant 72.78 showing significantly
increased caspase 3/7 activities compared with wild type (p 
0.05 or 0.0001, Student’s t test) that were not associated with
observed cell death. It was noted that the cells expressing wild
type S100A4 or mutant 72, 72.78, or 16.72.78 exhibited signifi-
cantly, 2–5-fold higher, caspase 3/7 activity in the two separate
S100A4 Self-association
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experiments than untransfected Rama 37 cells (wild type
S100A4, p 0.0002 and p 0.0001; mutant 72, p 0.0035 and
p  0.05; mutant 72.78, p  0.0001 and p  0.0001; mutant
16.72.78, p  0.0009 and p  0.006), whereas cells transfected
with empty PBKCMV or pCDNA3 exhibited significantly
decreased or not significantly increased caspase activity relative
to Rama 37 cells (pBKCMV p 0.46 and p 0.017; pCDNA3,
p 0.29 and p 0.86). It is possible that cells expressing wild
type andmutant S100A4proteins exhibit higher rates of growth
but also higher rates of apoptosis than mock-transfected/un-
transfected cells. However, it is probably more likely that the
S100A4-expressing cells exhibit a higher basal level of caspase
3/7 activity, an idea that is supported by the fact that caspase 3/7
activity in all cell lines tested could be further triggered by the
treatment of the cells with pro-caspase activator 1 (not shown).
Clones and pools that expressed the corresponding mutant
proteins at similar levels to one anotherwere selected (Fig. 1), as
determined by measuring the densities of the chemilumines-
cent Western blot bands and corrected for variations in actin
levels (mutant clones, 91%  S.D. 3.6 wild type clone; mutant
pools, 100% S.D. 9.3 wild type pool).
The transfected Rama 37 cloned cell lines and pools express-
ing S100A4 proteins bearing mutant 72, mutant 72.78, or
mutant 16.72.78 all exhibited a significantly reduced ability to
promote metastases in the lungs compared with wild type pro-
tein when injected into mammary fat pads of syngeneic rats
(Table 1). However, the reduction in metastasis-promoting
potential for mutant 72 (cell clone, 43% of rats against 90% of
rats forwild type S100A4,p 0.0029, Fisher’s ExactTest; trans-
fected cell pool, 57% of rats against 89% for wild type S100A4,
FIGURE 1. The level of wild type and mutant S100A4 proteins in trans-
fected Rama 37 cell clones and cell pools. Cells were transfected with
expression vectors containing S100A4 wild type or mutant 72, 72.78, or
16.72.78 cDNAs as described under “Experimental Procedures.” Extracts of
cloned cell lines (A and B) or pooled transfectants (C andD) were separatedby
SDS-PAGE and blotted onto polyvinylidene difluoride membranes. Mem-
branes were incubatedwith either a polyclonal S100A4 antibody (A and C) or
anti-actin serum (B and D) as a loading control. Bound antibodies were
detected by chemiluminescence with horseradish peroxidase-conjugated
secondary antibody as described previously (28, 30, 31). The intensities of the
bands of S100A4 protein corrected for actin levels in cloned cell lines, Rama
37, Rama 37  vector, Rama 37  S100A4 mutant 72, Rama 37  S100A4
mutant 72.78, and Rama 37  S100A4 mutant 16.72.78 were 16, 10, 95, 90,
and 88% that of wild type and, for cell pools, 10, 5, 99, 110, and 91% that of
wild type.
TABLE 1
Incidences of mammary tumors, metastases, and invasion in rats injected with various transfected cell lines
Transfected DNA (designation of cell line)a Incidence of mammarytumorsb p value
c Incidence of
metastasisd p value
e Incidence of
invasionf p value
g
% % %
None; untransfected Rama 37h 18/20 (90) p 0.99 0/20 (0) p 0.0001 0/20 (0) p 0.0001
Vector onlyh
Clone 19/20 (95) p 1.00 0/20 (0) p 0.0001
Pool 23/23 (100) p 1.00 2/23 (9) p 0.0001 3/18 (16) p 0.0001
S100A4 wild typeh
Clone 22/22 (100) 20/22 (90)
Pool 19/19 (100) 17/19 (89) 17/20 (85)
S100A4 mutant 72
Clone 16/16 (100) p 1.00 7/16 (43) p 0.0029
Pool 19/19 (100) p 1.00 11/19 (57) p 0.063 9/19 (47) p 0.017
S100A4 mutant 72.78
Clone 18/19 (94) p 1.00 3/19 (15) p 0.0001
Pool 21/23 (91) p 1.00 2/23 (8) p 0.0001 3/5 (60) p 0.289
S100A4 mutant 16.72.78
Clone 16/16 (100) p 1.00 0/16 (0) p 0.0001
Pool 14/15 (93) p 1.00 6/31 (19) p 0.0001 7/17 (41) p 0.007
a S100A4 mutant 72, cells expressing mutant S100A4 protein in which residue 72 has been changed from phenylalanine to glutamine; S100A4 mutant 72.78, cells expressing
mutant S100A4 protein in which residues 72 and 78 have been changed from phenylalanine to glutamine and alanine respectively; S100A4 mutant 16.72.78, cells expressing
mutant S100A4 protein in which residues 16, 72, and 78 have been changed from phenylalanine to alanine, glutamine, and alanine, respectively.
bNumber of tumors/number of animals inoculated.
c p values for tumor incidences in cloned or in pooled transfectant cells of mutant 72, mutant 72.78, and mutant 16.72.78 are compared with cloned or pooled transfectant cells
of the wild type S100A4 transfections (Fisher’s Exact test).
dNumbers of animals (%) with lung metastases/numbers of animals with tumors.
e p values for incidences of metastasis in cloned cell lines or in cell pools transfected with S100A4 mutant 72, mutant 72.78, mutant 16.72.78, empty pBKCMV vector, or cloned
untransfected Rama 37 cells compared with cloned or pooled transfectant cells of the wild type S100A4 transfections (Fisher’s Exact test).
fNumbers of animals (%) with muscle invasion/numbers of animals with muscle around tumors. No peripheral muscle tissue was recovered in sections of primary tumors from
10 rats with clones and 11 rats with pools of wild type S100A4, from 7 rats with clones and 9 rats with pools ofmutant 72, in 16 rats with clones and 21 rats with pools ofmutant
72.78, in 8 rats with clones and 22 rats with pools of mutant 16.72.78, and in 11 rats with clones and 14 rats with pools of pBKCMV vector transfected cells. In view of the low
proportion of primary tumors with muscle in the available histological sections of wild type, mutants, and vector control, the results for clones and pools were combined for
statistical analysis.
g p values for muscle invasion in tumors from combined cell lines and pooled transfectant cells of mutant 72, mutant 72.78, and mutant 16.72.78, pBKCMV vector or cloned
untransfected Rama 37 cells compared with combined cloned and pooled transfectant cells of the wild type S100A4 transfectants (Fisher’s Exact test).
h For purposes of comparison, the results for Rama 37 cells, vector, and S100A4 wild type cells were taken from a previous publication, Ismail et al. (28). The basic C-terminal
amino acids of calcium-binding protein S100A4 promote metastasis (28).
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p 0.0625, Fisher’s Exact Test) was less than for mutant 72.78
(cell clone, 15% of rats against 90% of rats for wild type S100A4,
p 0.0001, Fisher’s Exact Test; transfected cell pool, 8% of rats
against 89% for wild type S100A4, p  0.0001, Fisher’s Exact
Test) or mutant 16.72.78 (cell clone, 0% of rats against 90% of
rats forwild type S100A4,p 0.0001, Fisher’s ExactTest; trans-
fected cell pool, 19% of rats against 89% for wild type S100A4,
p  0.0001, Fisher’s Exact Test). These results show that the
mutations 72.78 and 16.72.78 had reduced the ability of S100A4
protein to promote metastases by more than 85%.
The effect of the mutations on the ability of S100A4 to
enhance the invasion of tumor cells into surroundingmuscle on
histological sections of primary tumors was examined. How-
ever, because of the absence ofmuscle in the sections of some of
the primary tumors, the results for invasion of cell clones and
pools were combined for each mutant (Table 1). S100A4
mutants 72 and 16.72.78 exhibited significantly reduced inva-
sion relative to wild type S100A4 (p  0.017 and p  0.007,
respectively, Fisher’s Exact Test). However, mutant 72.78 was
not significantly different from wild type protein (p  0.29),
probably reflecting the very small number of 72.78 tumors with
muscle blocks in the sections.
Using the Boyden chamber assay, the migration of the cells
expressing S100A4 mutant 72-transfected clone/pooled cells
was not significantly different from thewild type S100A4 clone/
pooled cells (p  0.99 test, Student’s t test; Fig. 2). However,
transfected clone/pool cells expressing S100A4mutant 72.78 or
S100A4 mutant 16.72.78 showed significantly reduced migra-
tion relative to clone/pool cells expressing wild type S100A4
(mutant 72.78 clone, p 0.0001 and pools, p 0.0009; mutant
16.72.78 clone, p 0.0003 and pool, p 0.0005 Student’s t test;
Fig. 2).
The abilities of themutant 72, 72.78, and 16.72.78 proteins to
bind calcium were determined using isothermal titration calo-
rimetry. The results showed that the mutant 72 protein bound
calciumwith aKd value of 31 10mM, a value that is consistent
with those obtained previously for S100 proteins (30, 36, 37)
albeit with reduced stoichiometry (supplemental Data 4). In
contrast, the binding of calcium ions for mutants 72.78 and
16.72.78 was too low to analyze.
The kinetics of interaction between rNMMIIHCA and
mutant proteins 72, 72.78, and 16.72.78 were determined in
vitro using an optical biosensor and compared with previously
obtained data for wild type S100A4 protein (28). For each
mutant the observed level of binding of S100A4 increased as the
concentration of S100A4 protein increased. A plot of the
observed on-rate (kon) against the concentration of S100A4
yielded a straight line. A plot of the slope of initial rate against
concentration of S100A4 yielded a straight line. Results
obtained from the binding curves with a one-site model
resulted in a near random distribution of the data about the
model. The data obtained covered at least 90% of the curve
described by the single-site model. The interaction of S100A4
with rNMMIIHCA was monophasic and was not limited by
diffusion (supplemental Data 5).
The kinetics of interaction of wild type S100A4 and three
interface mutant proteins with rNMMIIHCA showed a dra-
matic reduction in the kass in all themutants comparedwith the
wild type protein and a consequent increase in the equilibrium
dissociation constant Kd from the nM into the M range (Table
2), with mutant S100A4 proteins 72.78 and 16.72.78 exhibiting
lower affinities (14–16 and 13–15 M, respectively) than
mutant S100A4protein 72 (4.6–4.8M) for rNMMIIHCA.The
value of the Kd for the interaction between the mutant S100A4
proteins and rNMMHCIIA correlated significantly with both
migration in the Transwell assay (r2 0.935, p 0.033, linear
regression) andmetastasis (r2 0.939, p 0.031, linear regres-
sion) (Fig. 3).
To find out the effect of the mutations of S100A4 on its self-
association, purified wild type and mutant proteins were ana-
lyzed by Superdex 75 gel filtration chromatography in the
absence of calcium ions, employing the buffer used for the bio-
sensor experiments. Wild type S100A4 protein chromato-
graphed as a single peak with a relative molecular mass of 28
kDa, consistent with it being a dimer in solution (not shown).
Re-running the main peak after 17 h at 4 °C showed an absence
of higher molecular weight material (not shown). In contrast to
the wild type protein, the majority of the mutant proteins were
present in higher molecular weight associations. Analysis of
wild type and mutant proteins by Superdex 200 chromatogra-
phy in a TBS buffer showed a single peak for wild type S100A4
protein of molecular mass 	23 kDa, similar to that obtained
with Superdex 75, but themutant 72 protein chromatographed
heterogeneously with molecular masses in the range 9–110
kDa. Mutants 72.78 and 16.72.78, although heterogeneous in
size, chromatographed with a prominent peak of greater than
FIGURE2.Theeffects of interfacemutationsof S100A4onmetastasis and
invasion in vivo and S100A4-inducedmigration of Rama 37 cells in vitro.
Cell pools or clones of Rama 37 cells expressing wild type S100A4 ormutants
72, 72.78, or 16.72.78 were subjected to migration assays in quadruplicate
Transwell chambers as described under “Experimental Procedures.” Parental
Rama 37 cell line and cells transfected with empty vector were used as nega-
tive controls. For statistical analysis, at least four independent assays were
conducted on clones and four on pools of cells. The results were converted to
a percentage of wild type migration. The horizontal line denotes the basal
level of migration of the Rama 37 cells in the Transwell assay. Incidences of
metastasis and invasion are expressed as the percentages of animals with
primary tumors using data from Table 1.
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500 kDa (Fig. 4), thus, showing a higher degree of aggregation
than the mutant 72 protein. The results suggest that the point
mutations have seriously disrupted the normal dimerization of
the S100A4 protein. The addition of 0.5 mM Ca2 did not alter
the pattern of elution of the proteins, thus, showing that the
aggregation state of the mutants was not dependent upon the
presence of Ca2 ions (Fig. 4).
To find out whether these mutations to S100A4 protein
affected its ability to self-associate and to associate with
rNMMIIHCA inside living cells, FRET experiments using
FLIM were carried out in HeLa cells (“Experimental Proce-
dures”). The results (Fig. 5) showed a significant reduction in
the fluorescence lifetime of pAmCyan in cells transfected with
pAmCyan-wild type S100A4 and pYFP-wild type S100A4 con-
structs (7 cells weremeasured) compared with cells transfected
with pAmCyan-wild type S100A4 alone (9 cells weremeasured;
p 0.0001, Student’s t test; supplemental Data 6A), indicating
self-association of the S100A4 monomers, as described previ-
ously (18). Similarly, there was a significant reduction in the
fluorescence lifetime of pAmCyan in cells transfected with
pAmCyan-S100A4 mutant 72 and pYFP-S100A4 mutant 72
constructs (4 cells were measured) compared with cells trans-
fected with pAmCyan-S100A4 mutant 72 alone (5 cells were
measured; p  0.015, Student’s t test; supplemental Data 6A);
the results were not significantly different from pAmCyan-wild
type S100A4 and pYFP-wild type S100A4 (p 0.15, Student’s t
test; supplemental Data 6A), suggesting that mutant 72 is
able to self-associate in vivo. In contrast, there was a borderline
significant reduction in the fluorescence lifetime of pAmCyan
in cells transfected with pAmCyan-S100A4 mutant 72.78 and
pYFP-S100A4mutant 72.78 constructs (4 cells weremeasured)
compared with cells transfected with pAmCyan-S100A4
mutant 72.78 alone (5 cells weremeasured; p 0.053, Student’s
t test; supplemental Data 6A); fluorescence lifetime was signif-
TABLE 2
Kinetics of binding of mutant recombinant S100A4 proteins to immobilized recombinant C-terminal fragment of non-muscle myosin II heavy
chain
Proteina Kass S.E.b Correlation coefficientc Kdiss S.E.d Kd (kinetic)e Kdf (equilibrium)
M1s1 s1 nM nM
Wild type S100A4g 173,000 63,000 0.91 0.015 0.002 91 36 55 8
Mutant 72 5,000 1300 0.92 0.0237 0.0014 4,600 1270 4,800 440
Mutant 72.78 1,150 360 0.93 0.02 0.0023 16,000 5,400 14,600 8,700
Mutant 16.72.78 730 215 0.96 0.01 0.003 13,400 3,900 15,000 3,500
aMutants 72, 72.78, and 16.72.78 refer to S100A4 proteins in which phenylalanine residues at positions 16, 72, and 78 have been substituted with alanine, glutamine and alanine,
respectively.
b kass and S.E. from three experiments were derived as described previously (33).
c The correlation coefficient of the linear regression through kon values used for obtaining kass..
d kdiss of the mean S.E. of at least 5 values at high concentrations of S100A4. No evidence was found for a two-site model of dissociation, suggesting that the S100A4 binding
sites on NMMIIHCA were homogeneous.
e Kd kinetics were calculated from the ratio of kdiss/kass.
f Kd equilibrium was calculated from the extent of binding near equilibrium as described previously (33).
gWild type data are taken from a previous publication, Ismail et al. (28). The basic C-terminal amino acids of calcium-binding protein S100A4 promote metastasis (28).
FIGURE 3.Relationship betweenmotility,metastasis, and the interaction
of rNMMIIHCA with wild type and mutant S100A4 proteins. The equilib-
rium dissociation constants for the interaction of mutant S100A4 proteins
and immobilized rNMMIIHCA were determined using an optical biosensor
and plotted against the motility and metastasis-promoting properties of
Rama 37 cells expressing wild type or mutant S100A4 proteins.
FIGURE 4. Elution profile of S100A4wild type andmutant proteins on gel
filtrationchromatography.Sampleswereapplied toaSuperdex20010/300
GL columnequilibratedwith TBS in the absenceof (left-hand column) or in the
presence of 0.5 mM Ca2 (right-hand column). Proteins were separated at a
flow rate of 0.5 ml/min, and elution was monitored at 215 nm. The retention
timeswere related to those of standard proteins (“Experimental Procedures”)
to determine the molecular masses of the S100A4 wild type and mutant
proteins.
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icantly longer than for pAmCyan-wild type S100A4 and pYFP-
wild type S100A4 (p  0.0001, Student’s t test; supplemental
Data 6A), suggesting that mutant 72.78 was not able to self-
associate efficiently in vivo. For mutant 16.72.78 there was no
significant reduction in fluorescence lifetime of pAmCyan in
cells transfected with pAmCyan-S100A4 mutant 16.72.78 and
pYFP-S100A4 mutant 16.72.78 constructs (5 cells were mea-
sured) comparedwith cells transfectedwith pAmCyan-S100A4
mutant 16.72.78 alone (9 cells were measured; p  0.52, Stu-
dent’s t test; supplemental Data 6A), but the fluorescence life-
time was significantly different from pAmCyan-wild type
S100A4 and pYFP-wild type S100A4 (p  0.0001, Student’s t
test; supplemental Data 6A), showing that mutant 16.72.78 was
not able to self-associate in vivo. These results suggest that the
aggregation observed in vitro with the purified protein is not
evident in vivo, at least as detected by FLIM, and that mutants
72.78 and 16.72.78 fail to self-associate efficiently in vivo.
The wild type and mutant pAmCyan-S100A4 constructs
72.78 and 16.72.78 were tested for their ability to interact with
rNMMIIHCA-YFP in vivo. The results (Fig. 5) showed that for
cells transfected with pAmCyan-wild type S100A4 and pYFP-
rNMMIIHCA constructs (10 cells were measured), there was a
significant reduction in fluorescence lifetime compared with
cells transfected with pAmCyan-wild type S100A4 alone (p 
0.00016, Student’s t test; supplemental Data 6A) as reported
before (18). For cells transfected with pAmCyan-S100A4
mutant 72.78 and pYFP-rNMMIIHCA (7 cells weremeasured),
the fluorescence lifetime was not significantly different from
that of cells transfected with pAmCyan-S100A4 mutant 72.78
alone (p  0.285, Student’s t test; supplemental Data 6A) but
was significantly longer than from cells transfected with
pAmCyan-wild type S100A4 and pYFP-NMMIIHCA con-
structs (p 0.004, Student’s t test; supplemental Data 6A), sug-
gesting that mutant 72.78 fails to associate with rNMMIIHCA
in vivo. A similar result was obtained with pAmCyan-S100A4
mutant 16.72.78 and pYFP-NMMIIHCA (6 cells were mea-
sured), which exhibited a fluorescence lifetime of pAmCyan
that was not significantly different from that of pAmCyan-
S100A4mutant 16.72.78 alone (p 0.479, Student’s t test; sup-
plemental Data 6A) but significantly longer than pAmCyan-wild
type S100A4 and pYFP-NMMIIHCA constructs (p 0.048, Stu-
dent’s t test; supplemental Data 6A), suggesting that this mutant
also fails to interact with rNMMIIHCA in vivo.
In separate experiments (supplemental Data 6B) it was con-
firmed that cells transfected with pAmCyan-mutant 72.78 or
pAmCyan-mutant 16.72.78 together with pYFP-rNMMIIHCA
exhibited significantly longer fluorescence lifetimes than
pAmCyan-wild type S100A4 with pYFP-rNMMIIHCA (p 
0.0007 and p  0.0001, respectively, Student’s t test). It was
further shown that pAmCyan-mutant 72 also exhibited signif-
icantly longer fluorescence lifetimes than pAmCyan-wild type
S100A4with pYFP-rNMMIIHCA (p 0.0012), suggesting that
all three mutants of S100A4 had an impaired ability to interact
with rNMMIIHCA in living cells.
Mutations to S100A4 affected its calcium-dependent inter-
action with another potential target, p53, using the optical bio-
sensor (Table 3 and supplemental Data 7). Wild type S100A4
exhibitedKd values in the range 200–300 nM with immobilized
p53 protein, whereas the effect of all the interface mutants was
FIGURE 5. FLIM-FRET analysis. Fluorescence lifetime imaging of cells
expressing AmCyan-S100A4, YFP-S100A4, and myosin-YFP proteins are
shown. The interaction at the level of one living cell wasmeasured using laser
scanning microscopy as described under “Experimental Procedures.” Cells
expressingAmCyan-wild typeS100A4andYFP-wild typeS100A4 (7 cellswere
measured) and cells expressing AmCyan-S100A4mutant 72 protein and YFP-
S100A4 mutant 72 protein (4 cells were measured) exhibited significantly
reduced fluorescence lifetime compared with control cells expressing
AmCyan-wild type S100A4 alone (9 cells were measured) or AmCyanmutant
72 protein alone (5 cells were measured). In contrast, cells expressing
AmCyan-S100A4 mutant 72.78 and YFP-S100A4 mutant 72.78 (11 cells were
measured) or AmCyan-S100A4 mutant 16.72.78 and YFP-S100A4 mutant
16.72.78 (5 cellsweremeasured) did not show reduced fluorescence lifetimes
relative to controls expressing AmCyan-S100A4 mutant 72.78 (11 cells were
measured) or AmCyan-S100A4 mutant 16.72.78 alone (9 cells were mea-
sured). Am, AmCyan fluorescent protein; y, yellow fluorescent protein; wt,
wild type.
TABLE 3
Kinetics of binding of mutant recombinant S100A4 proteins to immobilized wild type p53
Proteina kass S.E.b Correlation coefficientc kdiss S.E.d Kd (kinetic)e Kd (equilibrium)f
M1s1 s1 nM nM
Wild type S100A4 65,000 1 000 0.93 0.016 0.003 243 72 190 10
Mutant 72 4,200 920 0.97 0.014 0.003 3,400 1000 1,800 720
Mutant 72.78 3,600 770 0.97 0.015 0.002 4,200 1110 1,400 450
Mutant 16.72.78 6,500 1,700 0.93 0.013 0.0005 2,000 540 1,400 230
aMutants 72, 72.78, and 16.72.78 refer to S100A4 proteins in which phenylalanine residues at positions 16, 72, and 78 have been substitutedwith alanine, glutamine, and alanine,
respectively.
b kass and S.E. from 3–5 experiments are derived as described previously (33).
c The correlation coefficient of the linear regression through kon values used for obtaining kass..
d kdiss of the mean S.E. of three values at high concentrations of S100A4. No evidence was found for a two-site model of dissociation, suggesting that the S100A4 binding sites
on p53 were homogeneous.
e Kd kinetics were calculated from the ratio of kdiss/kass.
f Kd equilibrium was calculated from the extent of binding near equilibrium as described previously (33).
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to increase the Kd	10-fold to M concentrations, mainly by a
decrease in the association rate constant (Table 3). The results
suggest that themutationswhich affect dimerization of S100A4
also reduce the affinity of its interaction with more than one of
its intracellular targets.
DISCUSSION
The effects of mutations in the dimer interface of S100A4 on
its target binding and metastasis-promoting ability have been
tested. Transfected cell lines and cell pools derived from the rat
mammary tumor-derived Rama 37 cells expressed the mutant
proteins at levels that were similar to those of cells expressing
wild type S100A4, suggesting that the mutations did not affect
the stability of the mutant proteins in the Rama 37 cells, in
contrast to human embryonic kidney cells, 293 (27). In vitro, the
purified mutant S100A4 proteins associated to produce large
aggregates, mutants 72.78 and 16.72.78 having a greater pro-
pensity to form higher molecular weight associations than the
mutant 72 protein. In living cells the results of the FRET-FLIM
experiments showed evidence for mutant 72-self-associating
similar to the wild type protein; however, mutants 72.78 and
16.72.78 were not significantly different from non-associating
controls, suggesting that thesemutant proteins do not show the
aggregate formation in vivo as they do in vitro. However, it is
possible, but considered unlikely, that the FRET assay fails to
detect the aggregates in living cells. It is also possible that the
mutant proteins fused to the cyan and yellow fluorescent pro-
teins do not aggregate to the same extent as the non-fused
proteins.
It is shown for the first time that the double mutant, 72.78,
and the triple mutant, 16.72.78, almost completely abolished
themetastasis-promoting ability of S100A4 protein in vivo and,
in the case of the triple mutant, reduced its invasion-inducing
ability. However, the small number of primary tumors that con-
tained muscle blocks on the histological sections of primary
tumors might have affected the results for the double mutant,
72.78.
There was a linear relationship between metastasis-promot-
ing ability and rate of cell migration (p 0.011, r2 0.837, 95%
confidence interval 0.4–0.99, linear regression) formutants 72,
72.78, and 16.72.78, as observed previously inmousemammary
tumor cells bearing S100A4 transgenes (19), further establish-
ing the link between S100A4-dependent cell migration and
metastasis.
In the dual immunofluorescence staining, S100A4was found
in between and at the ends of myosin fibers, raising the possi-
bility that S100A4 is associated with the dynamics of assembly
of the myosin fibers. Furthermore, in the cells expressing
mutant proteins 72.78 and 16.72.78, the myosin fibers were
collapsed around the periphery of the cell, further raising the
possibility that changes in the supramolecular structure of the
myosin filaments are associated with the loss of migration,
invasion, and metastasis in cells expressing mutant 72.78 or
16.72.78.
Measurement of the binding parameters of the interaction
between mutant S100A4 proteins and the S100A4 target,
rNMMIIHCA, in vitro showed that the three mutants, 72,
72.78, and 16.72.78 exhibited equilibrium dissociation con-
stants with rNMMIIHCA in the 5–15M range compared with
the low nM value for wild type S100A4 (28). There was an
inverse relationship between the value of the equilibrium dis-
sociation constant and the ability of the mutant proteins to
promote metastasis/invasion. Although in vitro the increased
equilibrium dissociation constant was associated with an
increasingly aggregated state of the protein, the FLIM FRET
results showed that mutants 72.78 and 16.72.78 did not self-
associate in vivo nor, importantly, did they interact with
rNMMIIHCA in vivo. These results suggest that proper
dimerization of S100A4 is necessary for its interaction with
myosin heavy chains and for S100A4-induced migration and
metastasis.
The results for S100A4 mutant 72 protein were less clear
cut. The 72mutant protein resembled wild type protein in its
abilities to bind calcium ions, to self-associate, and to induce
migration. However, it exhibited defective interaction with
rNMMIIHCA in vivo, partially reduced affinity for rNMMIIHCA
(Kd 4–5M) in vitro, and partially reducedmetastasis induction
relative to the 72.78 and 16.72.78 mutants. We have previously
shown (28) that deletion of 14 amino acids from the C terminus
of S100A4 (
14) yields a protein that exhibits near wild type
levels of migration but a Kd for myosin interaction in vitro of
3–4M, an	50%ofwild type level ofmetastasis induction, and
near wild type levels of Ca2 interaction, properties that are
similar to those of the current mutant 72 protein. In the case of
the 
14 mutant, it was suggested that previously described
interdimer interactions (38) had been disrupted. It is possible
that the mutation residue 72 causes changes in the structure of
the protein that only become evident in the longer term assays,
but the 72.78 and 16.72.78 mutations have more wide-ranging
effects on the S100A4 protein which abrogate Ca2 binding,
reduce myosin affinity further, and reduce migration and
metastasis closer to basal levels.
S100A4 interacts with a number of proposed, mainly intra-
cellular (16, 17, 21, 23, 24, 39, 40) but also extracellular (25),
protein targets. Of particular relevance in cancer is the interac-
tion of S100A4 with the tumor suppressor protein, p53 (21, 22,
33). It is now shown that disruption of normal S100A4 self-
association also disrupts the interaction of S100A4 with p53, at
least in vitro, using immobilized recombinant p53 protein in an
optical biosensor. In these experiments, the Kd values of the
interaction between thewild type S100A4 protein and p53were
of the order of 200 nM, somewhat lower than obtained previ-
ously using immobilized S100A4, where it adopts an altered,
calcium-independent conformation (33). In contrast, in the
present experiments recombinant p53 was immobilized on the
surface. The Kd values were lower than those in the M range
obtained using fluorescence anisotropy for a recombinant frag-
ment consisting of 100 amino acids from the C-terminal region
of p53 protein (22). In the present experiments the entire p53
protein was used, and the exact state of the p53 protein on the
biosensor surface after the acid regenerativewash is not known.
However, it has been proposed that S100A4 binds to the tet-
ramerization domain in the C-terminal regions of p53 when
exposed to lower oligomerization states of p53 (22). For inter-
action with p53, there was a large, 8–17-fold increase in the Kd
for the mutant proteins relative to the wild type S100A4 pro-
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tein, with a 14-fold increase in Kd evident with just the single
mutant, 72. The observation that it is possible to disrupt the
interaction between S100A4 and two proposed cancer-related
intracellular protein targets, rNMMIIHCA and p53, with just
two point mutations of amino acids conserved as phenylala-
nine/hydrophobic amino acids in 54 S100 proteins from fish to
humans (26), opens up the possibility of inhibiting the meta-
static action of S100A4 and other prometastatic S100 proteins,
such as S100P (41), by targeting the self-association of these
proteins.
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